WINDTREE THERAPEUTICS INC /DE/ Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 123 shares for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 120.00 shares, a 76.14% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-03-31 was 3.00 shares.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2024-12-31 was 19.35K shares, a 867.60% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 20.00K shares, a 42.86% increase from fiscal 2023.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 14.00K shares, a 75.00% increase from fiscal 2022.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 8.00K shares, a 94.16% decline from fiscal 2021.
- WINDTREE THERAPEUTICS INC /DE/ share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2021 was 137.00K shares, a 68.21% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2025-09-30 | 120.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | 120.00 shares derived: sum of 2 quarters · filed 2025-11-19 | 123.00 shares 10-Q · filed 2025-11-19 | 19.48K shares derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | 3.00 shares 10-Q · filed 2025-08-19 | 19.36K shares derived: sum of 3 quarters · filed 2025-08-19 | 19.86K shares derived: sum of 4 quarters · filed 2025-08-19 |
| 2025-03-31 | 3.00 shares 10-Q · filed 2025-05-15 | 19.36K shares derived: sum of 2 quarters · filed 2025-05-15 | 19.86K shares derived: sum of 3 quarters · filed 2025-05-15 | 20.00K shares derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | 19.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | 19.86K shares derived: sum of 2 quarters · filed 2025-04-15 | 20.00K shares derived: sum of 3 quarters · filed 2025-04-15 | 20.00K shares 10-K · filed 2025-04-15 |
| 2024-09-30 | 503.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-26 | 648.00 shares derived: sum of 2 quarters · filed 2024-11-26 | 648.00 shares 10-Q · filed 2024-11-26 | 2.65K shares derived: sum of 4 quarters · filed 2024-11-26 |
| 2024-06-30 | 145.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | 145.00 shares 10-Q · filed 2024-08-19 | 2.15K shares derived: sum of 3 quarters · filed 2024-08-19 | 4.14K shares derived: sum of 4 quarters · filed 2024-08-19 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-15 | 2.00K shares derived: sum of 2 quarters · filed 2024-05-15 | 4.00K shares derived: sum of 3 quarters · filed 2024-05-15 | 7.00K shares derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | 2.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | 4.00K shares derived: sum of 2 quarters · filed 2024-04-16 | 7.00K shares derived: sum of 3 quarters · filed 2024-04-16 | 14.00K shares 10-K · filed 2024-04-16 |
| 2023-09-30 | 2.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 5.00K shares derived: sum of 2 quarters · filed 2023-11-09 | 12.00K shares 10-Q · filed 2023-11-09 | -364.00K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 3.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 10.00K shares 10-Q · filed 2023-08-07 | -366.00K shares derived: sum of 3 quarters · filed 2023-08-07 | -202.00K shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 7.00K shares 10-Q · filed 2023-05-15 | -369.00K shares derived: sum of 2 quarters · filed 2023-05-15 | -205.00K shares derived: sum of 3 quarters · filed 2023-05-15 | -34.00K shares derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | -376.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -212.00K shares derived: sum of 2 quarters · filed 2023-03-31 | -41.00K shares derived: sum of 3 quarters · filed 2023-03-31 | 8.00K shares 10-K · filed 2023-03-31 |
| 2022-09-30 | 164.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 335.00K shares derived: sum of 2 quarters · filed 2022-11-14 | 384.00K shares 10-Q · filed 2022-11-14 | 402.00K shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | 171.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 220.00K shares 10-Q · filed 2022-08-11 | 238.00K shares derived: sum of 3 quarters · filed 2022-08-11 | 352.00K shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 49.00K shares 10-Q · filed 2022-05-05 | 67.00K shares derived: sum of 2 quarters · filed 2022-05-05 | 181.00K shares derived: sum of 3 quarters · filed 2022-05-05 | 184.00K shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 18.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 132.00K shares derived: sum of 2 quarters · filed 2022-03-31 | 135.00K shares derived: sum of 3 quarters · filed 2022-03-31 | 137.00K shares 10-K · filed 2022-03-31 |
| 2021-09-30 | 114.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 117.00K shares derived: sum of 2 quarters · filed 2021-11-10 | 119.00K shares 10-Q · filed 2021-11-10 | 148.00K shares derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | 3.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 5.00K shares 10-Q · filed 2021-08-05 | 34.00K shares derived: sum of 3 quarters · filed 2021-08-05 | 421.00K shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | 2.00K shares 10-Q · filed 2021-05-13 | 31.00K shares derived: sum of 2 quarters · filed 2021-05-13 | 418.00K shares derived: sum of 3 quarters · filed 2021-05-13 | 426.00K shares derived: sum of 4 quarters · filed 2021-05-13 |
| 2020-12-31 | 29.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | 416.00K shares derived: sum of 2 quarters · filed 2021-03-29 | 424.00K shares derived: sum of 3 quarters · filed 2021-03-29 | 431.00K shares 10-K · filed 2021-03-29 |
| 2020-09-30 | 387.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | 395.00K shares derived: sum of 2 quarters · filed 2020-11-16 | 402.00K shares 10-Q · filed 2020-11-16 | 643.00K shares derived: sum of 4 quarters · filed 2020-11-16 |
| 2020-06-30 | 8.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | 15.00K shares 10-Q · filed 2020-08-14 | 256.00K shares derived: sum of 3 quarters · filed 2020-08-14 | 256.00K shares derived: sum of 4 quarters · filed 2020-08-14 |
| 2020-03-31 | 7.00K shares 10-Q · filed 2020-05-13 | 248.00K shares derived: sum of 2 quarters · filed 2020-05-13 | 248.00K shares derived: sum of 3 quarters · filed 2020-05-13 | 249.00K shares derived: sum of 4 quarters · filed 2020-05-13 |
| 2019-12-31 | 241.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | 241.00K shares derived: sum of 2 quarters · filed 2020-04-03 | 242.00K shares derived: sum of 3 quarters · filed 2020-04-03 | 246.00K shares 10-K · filed 2020-04-03 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 1.00K shares derived: sum of 2 quarters · filed 2019-11-14 | 5.00K shares 10-Q · filed 2019-11-14 | 8.00K shares derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-06-30 | 1.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 5.00K shares 10-Q · filed 2019-08-14 | 8.00K shares derived: sum of 3 quarters · filed 2019-08-14 | 8.00K shares derived: sum of 4 quarters · filed 2019-08-14 |
| 2019-03-31 | 4.00K shares 10-Q · filed 2019-05-20 | 7.00K shares derived: sum of 2 quarters · filed 2019-05-20 | 7.00K shares derived: sum of 3 quarters · filed 2019-05-20 | 7.00K shares derived: sum of 4 quarters · filed 2019-05-20 |
| 2018-12-31 | 3.00K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-23 | 3.00K shares derived: sum of 2 quarters · filed 2019-04-23 | 3.00K shares derived: sum of 3 quarters · filed 2019-04-23 | 4.00K shares 10-K/A · filed 2019-04-23 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2018-11-14 | 1.00K shares 10-Q · filed 2018-11-14 | -243.00K shares derived: sum of 4 quarters · filed 2018-11-14 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 1.00K shares 10-Q · filed 2018-08-14 | -243.00K shares derived: sum of 3 quarters · filed 2018-08-14 | -38.00K shares derived: sum of 4 quarters · filed 2018-08-14 |
| 2018-03-31 | 1.00K shares 10-Q · filed 2018-05-21 | -243.00K shares derived: sum of 2 quarters · filed 2018-05-21 | -38.00K shares derived: sum of 3 quarters · filed 2018-05-21 | 14.00K shares derived: sum of 4 quarters · filed 2018-05-21 |
| 2017-12-31 | -244.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17 | -39.00K shares derived: sum of 2 quarters · filed 2018-04-17 | 13.00K shares derived: sum of 3 quarters · filed 2018-04-17 | 14.00K shares 10-K · filed 2018-04-17 |
| 2017-09-30 | 205.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | 257.00K shares derived: sum of 2 quarters · filed 2017-11-14 | 258.00K shares 10-Q · filed 2017-11-14 | 268.00K shares derived: sum of 4 quarters · filed 2017-11-14 |
| 2017-06-30 | 52.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-21 | 53.00K shares 10-Q · filed 2017-08-21 | 63.00K shares derived: sum of 3 quarters · filed 2017-08-21 | 200.89K shares derived: sum of 4 quarters · filed 2017-08-21 |
| 2017-03-31 | 1.00K shares 10-Q · filed 2017-05-15 | 11.00K shares derived: sum of 2 quarters · filed 2017-05-15 | 148.89K shares derived: sum of 3 quarters · filed 2017-05-15 | |
| 2016-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | 147.89K shares derived: sum of 2 quarters · filed 2017-03-31 | 148.00K shares 10-K · filed 2017-03-31 | |
| 2016-09-30 | 137.89K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 138.00K shares 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | 112.00 shares 10-Q · filed 2016-08-10 | |||
| 2015-12-31 | 135.00K shares 10-K · filed 2016-03-29 | |||
| 2014-12-31 | 663.00K shares 10-K · filed 2015-03-16 | |||
| 2013-12-31 | 479.00K shares 10-K · filed 2014-03-17 | |||
| 2012-12-31 | 162.00K shares 10-K · filed 2014-03-17 | |||
| 2011-12-31 | 276.00K shares 10-K · filed 2014-03-17 | |||
| 2010-12-31 | 142.00K shares 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |